Debut Plus

545.3

-33.14 -5.73%

17 Jul 2026

NSE Listed · Healthcare

Metropolis Healthcare Limited (METROPOLIS)

Volume: 1,51,11852W Range:412.25600
Market Cap₹11,308 Cr
Current Price₹545.3
Previous Close₹578.44
High / Low (52w)₹600 / ₹412.25
Volume1,51,118
Avg Vol (1W)
Avg Vol (1M)
Stock P/E59.27
Book Value₹73.13
Dividend Yield35%
ROE13.37%
ROA8.34%
Revenue (TTM)₹1,646 Cr
Revenue Growth
Profit Margin
Total Debt₹232 Cr
Shares Outstanding21 Cr
Face Value₹2
EPS (TTM)₹9.2
P/B7.46
Debt / Equity15.21
50 DMA₹542.15
200 DMA₹492.1
Day change-5.73%
Price Chart
545.3 11.63% · 1Y
57442316.4L
2025-07-17
2026-07-16

20-day avg volume: 3.2L shares

Pros
  • Pays a dividend yield of 35.0%.
  • Company is almost debt-free.
  • Revenue grew 24% YoY.
  • Net profit is growing year over year.
Cons
  • Stock trades at a high P/E of 59.
Quarterly Results
MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024
Revenue₹425 Cr₹406 Cr₹386 Cr₹345 Cr₹323 Cr
EBITDA₹116 Cr₹95 Cr₹97 Cr₹69 Cr₹75 Cr
Net Profit₹51 Cr₹41 Cr₹45 Cr₹29 Cr₹31 Cr
EPS2.461.992.532.171.42
Profit & Loss (Annual)
MetricMar 2026Mar 2025Mar 2024Mar 2023Mar 2022
Revenue₹1,646 Cr₹1,331 Cr₹1,208 Cr₹1,148 Cr
EBITDA₹417 Cr₹318 Cr₹292 Cr₹304 Cr
Net Profit₹190 Cr₹145 Cr₹128 Cr₹143 Cr
EPS9.197.046.226.95
Balance Sheet
MetricMar 2026Mar 2025Mar 2024Mar 2023Mar 2022
Total Assets₹2,138 Cr₹1,867 Cr₹1,555 Cr₹1,502 Cr
Total Liabilities₹613 Cr₹533 Cr₹456 Cr₹511 Cr
Equity₹1,513 Cr₹1,331 Cr₹1,096 Cr₹988 Cr
Total Debt₹232 Cr₹204 Cr₹197 Cr₹266 Cr
Cash Flow
MetricMar 2026Mar 2025Mar 2024Mar 2023Mar 2022
Operating₹351 Cr₹263 Cr₹264 Cr₹247 Cr
Investing₹-223 Cr₹-201 Cr₹-89 Cr₹47 Cr
Financing₹-115 Cr₹-87 Cr₹-181 Cr₹-292 Cr
Free Cash Flow₹300 Cr₹194 Cr₹200 Cr₹194 Cr
Shareholding
Promoter 48.86% Institutions 44.99% Public 6.15%
About Metropolis Healthcare Limited

Healthcare · Diagnostics & Research

Metropolis Healthcare Limited, together with its subsidiaries, provides pathology and related healthcare services in India, Africa, South Asia, the Middle East, and internationally. The company offers routine and semi-specialised pathology tests; advanced diagnostics, including genetic, molecular, and cytogenetic testing; preventive healthcare packages and corporate wellness screening; and clinical trial research, hospital lab management, and home collection services, as well as profiles, blood tests, and soft radiology services. It also provides diagnostic services for oncology, neurology, gynecology, and nephrology, as well as various health check-up packages for men, women, senior citizens, youth, and corporates. In addition, the company develops and deals in technology driven products and services. The company serves a range of customers, including direct-to-consumer diagnostics through patient service centers, a mobile app, a website, and home collection; partnerships with standalone labs, hospital chains, and diagnostic networks; and institutional clients, such as corporates, government bodies, and hospital lab management services. Metropolis Healthcare Limited was founded in 1980 and is headquartered in Mumbai, India.

www.metropolisindia.com
Technical AnalysisPremium

Technical analysis (Premium)

Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.

More stocks

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search